Cefotaxime Treatment of Pelvic Inflammatory Disease

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1981 Dec 1

PMID 6275789

Citations 2

Authors

T P Monson

T T Miller

C M Nolan

Affiliations

Soon will be listed here.

Abstract

We studied cefotaxime in the treatment of gonococcal and nongonococcal pelvic inflammatory disease. Cefotaxime was uniformly effective against gonococcal pelvic inflammatory disease. However, 4 of 11 patients with nongonococcal pelvic inflammatory disease had a suboptimal response.

Citing Articles

Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Carmine A, Brogden R, Heel R, Speight T, Avery G Drugs. 1983; 25(3):223-89.

PMID: 6303743 DOI: 10.2165/00003495-198325030-00001.

Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.

Phillips I Drugs. 1987; 34 Suppl 2:164-79.

PMID: 3319500 DOI: 10.2165/00003495-198700342-00013.

References

Bennett J, BRODIE J, BENNER E, KIRBY W . Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966; 14(2):170-7. PMC: 546645. DOI: 10.1128/am.14.2.170-177.1966. View

Gorbach S, Bartlett J . Editorial: Anaerobic infections: old myths and new realities. J Infect Dis. 1974; 130(3):307-10. DOI: 10.1093/infdis/130.3.307. View

Eschenbach D, Buchanan T, POLLOCK H, Forsyth P, ALEXANDER E, Lin J . Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med. 1975; 293(4):166-71. DOI: 10.1056/NEJM197507242930403. View

Hansen S, Stewart B . Comparison of API and Minitek to Center for Disease Control methods for the biochemical characterization of anaerobes. J Clin Microbiol. 1976; 4(3):227-31. PMC: 274441. DOI: 10.1128/jcm.4.3.227-231.1976. View

Murray P, Christman J, Medoff G . In vitro activity of HR 756, a new cephalosporin, against Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1979; 15(3):452-4. PMC: 352682. DOI: 10.1128/AAC.15.3.452. View